Author: admin

Acute pulmonary embolism is a relatively common and serious medical condition, and there is some uncertainty around the optimal treatment choice. There are tradeoffs among ventricular

CHDS’s James Hammitt presented two seminars at Duke University. The first, “Fair Innings: The Utilitarian and Prioritarian Value of Risk Reduction over a Whole Lifetime,” describes

A new book, The Future of Risk Management, features a chapter by CHDS researcher Lisa A. Robinson and co-authors W. Kip Viscusi and Richard J. Zeckhauser on the problems associated with consumer

A Lancet Public Health article by CHDS researchers has resulted in numerous news outlets featuring the research. Emily Burger and Jane Kim have given interviews to Newsweek, Popular Science, Gizmodo,

The Immunization Costing Action Network (ICAN) team announced new and updated materials on immunization delivery costs in low-and middle-income countries (LMICs).

CHDS faculty James K. Hammitt is quoted in several recent articles on the value of reducing deaths from the COVID pandemic, including the Wall Street Journal, fivethirtyeight.com, and Forbes.

Dr. Ruanne V. Barnabas, Associate Professor at the University of Washington, presented a health decision science seminar at CHDS on Community-Based Treatment, Monitoring

Recent research by PhD candidate and CHDS programmer/analyst Zachary Ward has been featured in multiple media outlets. The article, published in the New England Journal of Medicine

CHDS faculty Jane Kim assumes the leadership role as Dean for Academic Affairs at the Harvard T.H Chan School of Public Health, serving under Dean of the Faculty, Michelle A. Williams. Jane is a Professor

CHDS hosted Assistant Professor Stéphane Verguet as part of a Media Hub residency with Hub lead Jake Waxman. Focused on the development of educational materials related to extended cost-effectiveness analysis (ECEA)